Mesalazine-Associated Agranulocytosis
- PMID: 39413358
- PMCID: PMC11867795
- DOI: 10.1097/MJT.0000000000001832
Mesalazine-Associated Agranulocytosis
Conflict of interest statement
The authors have no conflicts of interest to declare.
References
-
- Sandborn WJ, Hanauer SB. Systematic review: the pharmacokinetic profiles of oral mesalazine formulations and mesalazine pro-drugs used in the management of ulcerative colitis. Aliment Pharmacol Ther. 2003;17:29–42. - PubMed
-
- Gisbert JP, González-Lama Y, Maté J. 5-Aminosalicylates and renal function in inflammatory bowel disease: a systematic review. Inflamm Bowel Dis. 2007;13:629–638. - PubMed
-
- Red Blood Cell Diseases (Anemia) Group of the Hematology Branch of the Chinese Medical Association. Chinese expert consensus on the diagnosis and treatment of neutropenia. Chin Med J. 2022;102:3167–3173.
LinkOut - more resources
Full Text Sources